SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (6562)6/23/1998 9:04:00 PM
From: LarryS  Read Replies (1) | Respond to of 17367
 
Someone posted here or on Yahoo that
M Murphy on Friday placed XOMA back on his
recommended list....now I don't want to
sound like Oliver Stone but surely
M Murphy didn't know about Orphan
approval before we did, did he??

I think this new status will bring added value and interest to XOMA and maybe some of those institutions waiting on the sidelines will buy now, while it is
still cheap.
Maybe $6 by Friday?....September?...early
next year?

Adults in England....XOMA couldn't be
conducting tests for the equivalent of their FDA, without informing us could they?



To: aknahow who wrote (6562)6/23/1998 10:07:00 PM
From: Tharos  Respond to of 17367
 
Given the promising results in BPI re trauma, you might want to make sure you local emergency rooms are enrolled in the program so that when opilapril or Ellen shoot you there is a chance of recovery ;-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News